Andere Sprachen Respiri Limited

Aktien

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:14 28.06.2024			% 5 Tage	% 1. Jan.
0,026 ^AUD	+13,04 %		-3,70 %	-13,33 %

05.06.	Respiri sammelt AU$1 Million durch zusätzliche Platzierung; Aktien fallen um 7%	MT
09.05.	Transcript : Respiri Limited - Special Call

Respiri Raises AU$1 Million via Additional Placement; Shares Down 7%	05.06.
Respiri to Raise AU$1.6 Million via Placement	30.04.
Respiri Partners with Hawaii Independent Physician Association for Remote Patient Monitoring Program; Shares Up 3%	29.04.
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29.02.
Respiri Limited Announces Executive Changes	28.01.
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	25.01.
Respiri Limited Appoints Tom Takubo as Non-Executive Director	13.12.
Respiri Limited Announces Resignation of Brian Leedman as Non-Executive Director	03.11.
Respiri Limited Secures Two Additional Healthcare Provider Contract	29.09.23
Australian Bourse Halts Trading in Respiri’s Securities	14.09.23
Respiri Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31.08.23
Respiri Completes Access Manages Services Acquisition	14.08.23
Respiri Completes AU$3 Million Share Purchase Plan	08.08.23
Respiri Extends Closing Date of Share Purchase Plan	25.07.23
Respiri Signs Marketing Agreement for Wheezo Device with Fi-Med Management	10.07.23
Respiri Limited Appoints Brian Leedman as Non-Executive Director	23.05.23
Respiri Appoints Chief Commercial Officer for US Market	12.04.23
Respiri Limited Appoints William Sigsbee as Chief Commercial Officer for the US Market	12.04.23
L'agenda di domani	27.02.23
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27.02.23

Keine Ergebnisse zu dieser Suche